Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effect of Intravenous Anesthetics on Fear Learning and Memory
This study is ongoing, but not recruiting participants.

First Received on October 3, 2008.   Last Updated on September 28, 2011   History of Changes
Sponsor: Weill Medical College of Cornell University
Collaborators: National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Information provided by (Responsible Party): Kane Pryor, Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT00767767
  Purpose

People often develop fearful responses to things, but have no conscious control over the fear (e.g. phobias). This is a basic form of unconscious memory, called "fear conditioning." Intravenous anesthetic drugs have remarkable effects on conscious memory, but it is unknown whether they have similar effects on these unconscious fear memories.

To address this question, the investigators will study 114 healthy adult volunteer subjects. The subject is given a very low dose of an anesthetic drug intravenously (i.e. through the bloodstream). The dose is so low that the subject might not even be able tell if they are getting the drug. While they are receiving the drug, the subject will perform a series of memory tests and a fear conditioning experiment, which are set up like a very simple computer game. To create the "fear response", subjects will occasionally receive a mildly uncomfortable shock to their arm. The subject is able to determine the highest level of shock that they will receive.

The investigators are doing this study because the investigators wish to know exactly how the drugs affect the way people process fear and emotion. This knowledge might one day be used in the treatment of some psychiatric disorders.


Condition Intervention
Phobias
Drug: Propofol
Drug: Placebo
Drug: Thiopental
Drug: Midazolam
Drug: Dexmedetomidine

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: The Effect of Intravenous Anesthetics on Fear Learning and Memory

Resource links provided by NLM:


Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:
  • Changes in skin conductance [ Time Frame: Throughout Study ] [ Designated as safety issue: No ]
  • Changes in the eye-blink reflex following an auditory startle probe [ Time Frame: Throughout Study ] [ Designated as safety issue: No ]
  • Changes in heart-rate variability [ Time Frame: Throughout Study ] [ Designated as safety issue: No ]

Estimated Enrollment: 90
Study Start Date: October 2008
Estimated Study Completion Date: December 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: 1
Saline Infusion.
Drug: Placebo
IV Saline infusion for 2 hours.
Active Comparator: 2
Anesthetic Drug Infusion.
Drug: Propofol
IV Propofol infusion for 2 hours.
Drug: Thiopental
IV Thiopental infusion for 2 hours.
Drug: Midazolam
IV Midazolam infusion for 2 hours.
Drug: Dexmedetomidine
IV Dexmedetomidine Infusion for 2 hours.

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • age between 18 and 50
  • minimum of high school education
  • fluent in English
  • normal vocabulary

Exclusion Criteria:

  • any significant medical or psychiatric comorbidity (e.g. asthma, diabetes, hypertension, depression, high anxiety)--subjects must be in excellent health such that they would be classified as American Society of Anesthesiologists Physical Status Class I
  • deficit in vision or hearing that would impede the study
  • allergies to any of the study drugs, to soybeans, or to eggs
  • a history of head trauma
  • a family history of major psychiatric illness
  • body mass index > 30 kg/m2
  • a recent history of recreational drug use
  • prior exposure to the study materials
  • pregnancy
  • a personal or family history of any porphyria
  • failure to exhibit a skin conductance response to deep inspiration
  • the ability to read Chinese characters
  • assessment by the investigators that the subject may be unable to cooperate or comply with the study requirements.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00767767

Locations
United States, New York
Weill Cornell Medical College/New York Presbyterian Hospital
New York, New York, United States, 10065
Sponsors and Collaborators
Weill Medical College of Cornell University
Investigators
Principal Investigator: Kane Pryor, MD Weill Medical College of Cornell University
  More Information

No publications provided

Responsible Party: Kane Pryor, Director of Clinical Research, Anesthesiology, Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT00767767     History of Changes
Other Study ID Numbers: 0710009434, K08GM083213
Study First Received: October 3, 2008
Last Updated: September 28, 2011
Health Authority: United States: Institutional Review Board;   United States: Food and Drug Administration

Keywords provided by Weill Medical College of Cornell University:
To investigate the effects of anesthetic drugs on associative memory processes involving fear

Additional relevant MeSH terms:
Phobic Disorders
Anxiety Disorders
Mental Disorders
Anesthetics
Midazolam
Propofol
Thiopental
Dexmedetomidine
Anesthetics, Intravenous
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses
Adjuvants, Anesthesia
Anti-Anxiety Agents
Tranquilizing Agents
Psychotropic Drugs
Hypnotics and Sedatives
Anesthetics, General
GABA Modulators
GABA Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Anticonvulsants
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Adrenergic alpha-2 Receptor Agonists

ClinicalTrials.gov processed this record on February 12, 2012